文献速递神经肿瘤

5-氨基乙酰丙酸后原卟啉IX在恶性胶质瘤中的实时荧光动力学测量

Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas.
PubMed 文献 · Neurosurgery · 2019-01-01

本研究在68例恶性胶质瘤患者术中,用高光谱相机测量5-ALA(20 mg/kg体重)给药后肿瘤荧光强度和原卟啉IX浓度随时间的变化。共分析201个样本,发现荧光峰值出现在给药后7至8小时,弱荧光边缘峰值更晚(8-9小时),提示5-ALA应在术前4至5小时给药。

要点

  • 5-ALA荧光峰值在给药后7至8小时,晚于既往认为的3小时。
  • 边缘弱荧光峰值(8-9小时)晚于中央强荧光(7-8小时)。
  • 建议5-ALA在术前4至5小时给药,并根据流程调整时机。

核心结论

  • 人脑恶性胶质瘤中5-ALA诱导的荧光峰值晚于既往认识,建议术前4至5小时给药。

研究设计与样本

  • 前瞻性术中测量研究,68例患者接受5-ALA 20 mg/kg体重,术前3至4小时给药,共分析201个样本。

主要发现

  • 荧光强度和估算原卟啉IX浓度平均最大值出现在5-ALA给药后7至8小时。
  • 荧光强度和原卟啉IX浓度可可靠区分中央强荧光与边缘弱荧光,以及III级与IV级胶质瘤。
  • 边缘弱荧光峰值出现于8-9小时,晚于强荧光的7-8小时。

关键数值与推荐

  • 5-ALA剂量为20 mg/kg体重,术前3至4小时给药。
  • 荧光强度和原卟啉IX浓度最大值在给药后7至8小时。
  • 弱荧光峰值在8-9小时,强荧光峰值在7-8小时。

临床怎么用

  • 5-ALA应在术前4至5小时给药,并根据内部流程和接近肿瘤的因素调整时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Five-aminolevulinic acid (5-ALA) is well established for fluorescence-guided resections of malignant gliomas by eliciting the accumulation of fluorescent protoporphyrin IX (PpIX) in tumors. Because of the assumed time point of peak fluorescence, 5-ALA is recommended to be administered 3 h before surgery. However, the actual time dependency of tumor fluorescence has not yet been evaluated in humans and may have important implications. OBJECTIVE: To investigate the time dependency of PpIX by measuring fluorescence intensities in tumors at various time points during surgery. METHODS: Patients received 5-ALA (20 mg/kg b.w.) 3 to 4 h before surgery. Fluorescence intensities (FI) and estimated tumor PpIX concentrations (CPPIX) were measured in the tumors over time with a hyperspectral camera. CPPIX was assessed using hyperspectral imaging and by evaluating fluorescence phantoms with known CPPIX. RESULTS: A total of 201 samples from 68 patients were included in this study. On average, maximum values of calculated FI and CPPIX were observed between 7 and 8 h after 5-ALA administration. FI and CPPIX both reliably distinguished central strong and marginal weak fluorescence, and grade III compared to grade IV gliomas. Interestingly, marginal (weak) fluorescence was observed to peak later than strong fluorescence (8-9 vs 7-8 h). CONCLUSION: In human in Situ brain tumor tissue, we determined fluorescence after 5-ALA administration to be maximal later than previously thought. In consequence, 5-ALA should be administered 4 to 5 h before surgery, with timing adjusted to internal logistical circumstances and factors related to approaching the tumor.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Kaneko S, Suero Molina E, Ewelt C, et al. Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas. Neurosurgery. 2019. PMID: 31058995. doi:10.1093/neuros/nyz129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。